Medtronic CFO Gary Ellis tells analysts that the $50 billion acquisition of Covidien pushes its available free cash flow from 35% to 60%, or about $7 billion annually.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/17ON4pj
Cap comentari:
Publica un comentari a l'entrada